Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Extension Study to Phase IIb Dose-finding Study of Entacapone in Patients With Parkinson's Disease With End-of-dose Wearing-off

NCT00237263 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00237263
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00237263 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Extension Study to Phase IIb Dose-finding Study of Entacapone in Patients With Parkinson's Disease With End-of-dose Wearing-off
Lead sponsor
Novartis
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2003
Completion date
July 31, 2007
Enrollment
285 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease